Ramdas Borhade: IL-17, Endothelial Activation and Thrombosis Prediction in Cancer
Ramdas Borhade, Deputy General Manager at Murali Krishna Pharma PVT LTD, shared on LinkedIn about a recent article by Dimitra Karagkouni et al, published in Science Translational Medicine, adding:
”Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17–driven endothelial activation | Science Translational Medicine.”
Title: Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17–driven endothelial activation
Authors: Dimitra Karagkouni, Marisa A. Brake, Rushad Patell, Anna Falanga, Marina Marchetti, Laura Russo, Simon Mantha, Donna Neuberg, Thita Chiasakul, Marc Carrier, Philip S. Wells, Robert E. Gerszten, Robert Flaumenhaft, Daniel Hui, Ioannis S. Vlachos, Sol Schulman, Jeffrey I. Zwicker
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 17, 2026, 16:30Daria Camilli: Empowering Bleeding Disorder Advocacy Through Health Economics
-
Sep 17, 2026, 16:17Mehran Ghasemzadeh: Platelet NK Cell Crosstalk in Advanced Coronary Artery Disease
-
Sep 17, 2026, 16:16Barbara Adams Krolak: Do GLP-1s Affect Blood Clot Risk?
-
Sep 17, 2026, 15:46Heghine Khachatryan: Clinical Context at the Core of Thrombosis and Thrombophilia Management
-
Sep 17, 2026, 15:33Alexandros Makis: When Microcytic Anemia Has an Inherited Cause
-
Sep 17, 2026, 15:22α2-Antiplasmin Inhibition and the Future of Thrombolysis
-
Sep 17, 2026, 15:20Fatma M. Attia: Expanding the Evidence Base for Therapeutic Plasma Exchange Across Multiple Indications
-
Sep 17, 2026, 15:19Conan McIlwrath: The Haemophilia Society Engages With IBCA
-
Sep 17, 2026, 15:06Eleftheria Hatzimichael: A Contemporary Diagnostic Approach to Inherited Microcytic Anemias